LM Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$294K Buy
6,785
+6,513
+2,394% +$354K 0.03% 196
2026
Q1
$4.34K Buy
272
+6
+2% +$480 0.07% 135
2025
Q4
$2.79K Sell
266
-2,531
-90% -$248K 0.05% 159
2025
Q3
$273K Buy
2,797
+97
+4% +$10K 0.04% 180
2025
Q2
$290K Sell
2,700
-27
-1% -$2.73K 0.04% 159
2025
Q1
$275K Buy
2,727
+27
+1% +$2.72K 0.05% 190
2024
Q4
$241K Hold
2,700
0.04% 173
2024
Q3
$226K Buy
+2,700
New +$213K 0.05% 162
2024
Q1
Sell
-700
Closed -$40.5K 276
2023
Q4
$40.5K Buy
+700
New +$37.4K 0.01% 354

Other funds holding BSX

LM Advisors's BSX Position: Q2 2026 in Review

LM Advisors increased its Boston Scientific (BSX) stake by 2,394% in Q2 2026, buying an estimated $354K and bringing the position to 6,785 shares worth $294K. The position accounts for 0.03% of the portfolio, ranked #196.

LM Advisors first reported a position in BSX in Q4 2023 and has held it in 9 quarters since. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • LM Advisors held 6,785 shares of Boston Scientific worth $294K as of Q2 2026.
  • LM Advisors bought 6,513 Boston Scientific shares in Q2 2026, an estimated $354K.
  • Boston Scientific made up 0.03% of LM Advisors's portfolio in Q2 2026, its #196 holding.
  • LM Advisors first reported a position in Boston Scientific in Q4 2023 and has held it in 9 quarters since.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on LM Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.